Article Text

PDF

GW23-e0959
CLINICAL CHARACTERISTICS OF 53 CASES OF NON-ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION
  1. Wei Xiao-jun,
  2. Liao Wei,
  3. Xie Dong-Yang,
  4. Wei Xiao-jun
  1. Department of Cardiology, Affiliated Hospital of Gannan Medical College, GanZhou, JiangXi 341000

    Abstract

    Objectives To explore the clinical features of non-ST-segment elevated acute myocardial infarction.

    Methods The differences between non-ST-segment elevation group (group A) and ST-segment elevation group (group B) were compared, such as risk factors of coronary heart disease, clinical presentation and prognosis (angina pectoris during peri-infarction period, infarct extension or reinfarction, cardiac pump failure, incidence of atrial fibrillation and ventricular arrhythmias, and hospital mortality within 4 week), peak serum myocardial enzymes and the results of coronary angiography.

    Results No significant differences were found in risk factors of coronary heart disease, infarct extension or rein fraction (p>0.05). The incidence of angina pectoris during peri-infarction period in group A was higher than that in group B, but cardiac pump failure, incidence of atrial fibrillation and ventricular arrhythmias, and hospital mortality within 4 week were lower than that in group B (p<0.05). Serum myocardial enzymes reached the peak after (14.2±2.6) h in group A and (23.6±15.6) h in group B (p<0.05). Significant differences were found in incidence of multi-vessel lesions (81.1% vs 38.2%, p<0.05) and single-vessel lesion (18.9% vs 61.8%, p<0.05) by Coronary angiography between group A and group B.

    Conclusions Clinical symptoms are often mild and hospital complication rate is often lower in patients with non-ST-segment elevated acute myocardial infarction. But because of its more multi-vessel lesions and severe underlying diseases, so its long-term prognosis is poor. Intravenous or intracoronary thrombolysis is often not beneficial. Percutaneous transluminal coronary angioplasty or coronary artery bypass grafting is the best choice to improve the long-term prognosis.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.